All In MedTech

FDA Clearance Tracker · P960009-S486

Activa and Percept Deep Brain Stimulation Therapy System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 23, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 23, 2024

Approved

Time to decision

84 days

Received Sep 30, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P960009-S486
Device name
Activa and Percept Deep Brain Stimulation Therapy System
Applicant location
Minneapolis, MN
Received
Sep 30, 2024
Decided
Dec 23, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

Approval for changes to the sterile barrier packaging and shelf box changes, instructions for use (IFU) and package labels, and reduction in labeled shelf life from 48 months to 24 months for the Medtronic Pocket Adaptor Kits (Model 64001 1x4 and Model 64002 2x4) for Deep Brain Stimulation.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.